トラベルワクチンの世界市場レポート 2024

トラベルワクチンの市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には9.1%の年間複合成長率（CAGR）で67億9,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、出張の頻度の増加、感染症による脅威の出現、政府の規制と入国要件、エキゾチックな目的地への需要の高まり、政府と製薬会社の協力努力に起因すると考えられます。予測期間中に予想される顕著な動向には、カスタマイズされたワクチン接種戦略の実施、非流行地域への市場拡大、デジタルヘルス技術の採用、規制支援、承認の合理化、革新的な開発などが含まれます。

予想される旅行と観光の急増により、将来的にトラベルワクチン市場の拡大が促進される見込みです。旅行と観光には、電車、船、飛行機、その他の交通手段を含む、地理的に離れたさまざまな地域にわたる人や車両の移動が含まれます。 トラベルワクチンは、海外旅行中の観光客や旅行者の安全と健康を確保する上で重要な役割を果たします。 2023年1月の時点で、国連世界観光機関（UNWTO）は、2022年には9億人を超える観光客が海外を旅行し、前年比2倍、パンデミック前のレベルから63％の大幅な増加を記録したと報告しました。この旅行と観光の急増は、トラベルワクチン市場の成長を推進する重要な要因です。

ヘルスケア支出の増加もトラベルワクチン市場拡大のもう一つの原動力となっています。ヘルスケア支出とは、特定の地域、国、または組織内のヘルスケア部門に割り当てられた財源の合計を指します。ヘルスケア支出のうち、予防策としてのトラベルワクチンへの投資は、旅行関連疾患の治療に伴う経済的負担の軽減に貢献します。これらのワクチンは、海外旅行中の感染症のリスクを最小限に抑え、それによって治療、入院、帰国後の感染の可能性などに関連する費用を回避することで、公衆衛生において重要な役割を果たしています。 2023年3月、米国医師協会は、米国の医療支出が2.7%増加し、2021年には4兆3,000億米ドル、つまり一人当たり1万2,914米ドルに達すると報告しました。このヘルスケア支出の増加は、トラベルワクチン市場の成長の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界のトラベルワクチン市場促進要因と制約要因
  • 市場の促進要因
  • 市場の抑制要因
• 世界のトラベルワクチンの市場規模実績と成長、2018年から2023年
• 世界のトラベルワクチン市場規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のトラベルワクチン市場、疾患別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• A型肝炎
• ジフテリア、百日咳、破傷風（DPT）
• 黄熱病
• 腸チフス
• B型肝炎
• 麻疹とおたふく風邪
• 狂犬病
• 髄膜炎菌
• その他の病気
• 世界のトラベルワクチン市場、構成別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 単一ワクチン
• 混合ワクチン
• 世界のトラベルワクチン市場、予約チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• オンライン予約
• 直接予約
• 世界のトラベルワクチン市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 国内旅行
• アウトバウンド旅行

第7章 地域および国の分析

• 世界のトラベルワクチン市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界のトラベルワクチン市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• トラベルワクチン市場の競合情勢
• トラベルワクチン市場の企業プロファイル
  • Pfizer Inc.
  • Johnson and Johnson
  • Merck &Co. Inc.
  • Novartis AG
  • Sanofi SA

第31章 その他の大手および革新的な企業

• AstraZeneca PLC.
• GlaxoSmithKline plc
• Moderna Inc.
• BioNTech Europe GmbH
• Biological E. Limited
• Bausch Health Companies Inc.
• Takeda Pharmaceutical Company Limited
• Novavax Inc.
• Emergent BioSolutions UK
• Serum Institute of India Pvt. Ltd.
• Dynavax Technologies
• Bavarian Nordic A/S
• Valneva SE
• Panacea Biotec
• Vabiotech

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Travel vaccines are immunizations designed to protect against diseases prevalent in either the country of origin or the destination. Their purpose is to ensure the well-being of travelers and prevent the transmission of diseases within and between nations.

The primary travel vaccines targeting various diseases include hepatitis A, diphtheria, pertussis, and tetanus (DPT), yellow fever, typhoid, hepatitis B, measles and mumps, rabies, meningococcal, and others. Hepatitis A is caused by the hepatitis A virus (HAV), leading to liver inflammation. These vaccines are available as mono vaccines or combination vaccines and can be booked through online and in-person channels for domestic travel, as well as through outbound travel applications.

The travel vaccine market research report is one of a series of new reports from The Business Research Company that provides travel vaccine market statistics, including the travel vaccine industry global market size, regional shares, competitors with a travel vaccine market share, detailed travel vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the travel vaccine industry. This travel vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The travel vaccines market size has grown strongly in recent years. It will grow from $4.41 billion in 2023 to $4.79 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. The expansion observed in the historical period can be attributed to the rise in international travel, government initiatives promoting travel health, the globalization of diseases, increased awareness among travelers, and the growth of the travel and tourism industry.

The travel vaccines market size is expected to see strong growth in the next few years. It will grow to $6.79 billion in 2028 at a compound annual growth rate (CAGR) of 9.1%. The anticipated growth in the forecast period can be attributed to the increasing frequency of business travel, the emergence of threats from infectious diseases, government regulations and entry requirements, a rising demand for exotic destinations, and collaborative efforts between governments and pharmaceutical companies. Prominent trends expected during the forecast period include the implementation of tailored vaccination strategies, the expansion of the market to non-endemic regions, the adoption of digital health technologies, regulatory support, streamlined approvals, and innovative developments.

The anticipated surge in travel and tourism is poised to drive the expansion of the travel vaccine market in the future. Travel and tourism encompass the movement of people and vehicles across various distant geographic areas, including trains, boats, airplanes, and other modes of transportation. Travel vaccines play a crucial role in ensuring the safety and health of tourists and travelers during their journeys abroad. As of January 2023, the United Nations World Tourism Organization (UNWTO) reported that over 900 million tourists ventured abroad in 2022, marking a twofold increase from the previous year and a substantial 63% rise from pre-pandemic levels. This surge in travel and tourism is a significant factor propelling the growth of the travel vaccine market.

The upswing in healthcare spending is another driving force behind the expansion of the travel vaccine market. Healthcare spending refers to the total financial resources allocated to the healthcare sector within a specific region, country, or organization. Within healthcare spending, investments in travel vaccines as preventive measures contribute to reducing the economic burden associated with treating travel-related diseases. These vaccines play a crucial role in public health by minimizing the risk of infectious diseases during international travel, thereby averting the costs linked to medical treatment, hospitalization, and potential outbreaks upon return. In March 2023, the American Medical Association reported a 2.7% increase in health spending in the United States, reaching $4.3 trillion or $12,914 per capita in 2021. This uptick in healthcare spending is a driving factor for the growth of the travel vaccine market.

Product innovation stands out as a prominent trend gaining traction in the travel vaccine market, with major companies actively pursuing the development of innovative vaccines to strengthen their market positions. For example, in August 2022, Takeda Pharmaceutical Company Limited, a Japan-based pharmaceutical company, received approval for QDENGA (Dengue Tetravalent Vaccine) (TAK-003) from the Indonesia National Agency for Drug and Food Control. QDENGA, designed for the prevention of dengue sickness in individuals aged six to 45, demonstrated sustained overall protection against dengue sickness and hospitalization three years after immunization, regardless of prior exposure to the disease.

Leading companies in the travel vaccine market are investing in innovative vaccines designed for active immunization against tick-borne encephalitis (TBE) for travel purposes. An example is Pfizer Inc., a US-based pharmaceutical and biotechnology company, which in August 2021 launched TICOVAC, the only FDA-approved vaccine for U.S. adults and children to help protect against the TBE virus when traveling or residing in TBE-endemic areas. TICOVAC's specific dosage and vaccination schedule depend on the age of the individual, offering a preventive measure for those traveling to endemic areas.

In May 2023, Bavarian Nordic, a US-based biopharmaceutical company, acquired Emergent BioSolutions' travel vaccine portfolio for an undisclosed amount. This strategic acquisition includes two commercially available vaccines-Vivotif for preventing typhoid fever and Vaxchora for cholera prevention-as well as a Phase 3 vaccine candidate targeting the prevention of the Chikungunya virus. The deal also encompasses R&D facilities in the US, a Swiss biologics production facility, and EU and US commercial operations with a specialized salesforce. Emergent BioSolutions, a US-based biotechnology firm, specialized in manufacturing devices, vaccines, and therapeutics, with its travel vaccine division being part of the acquisition.

Major companies operating in the travel vaccines market report are Pfizer Inc., Johnson and Johnson, Merck & Co. Inc., Novartis AG, Sanofi SA, AstraZeneca PLC., GlaxoSmithKline PLC, Moderna Inc., BioNTech Europe GmbH, Biological E. Limited, Bausch Health Companies Inc., Takeda Pharmaceutical Company Limited, Novavax Inc., Emergent BioSolutions UK, Serum Institute of India Pvt. Ltd., Dynavax Technologies, Bavarian Nordic A/S, Valneva SE, Panacea Biotec, Vabiotech, Inovio Pharmaceuticals, Bharat Biotech International Limited, Altimmune Inc., Bio Farma, Vaxart Inc.

North America was the largest region in the travel vaccines market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the travel vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the travel vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The travel vaccine market consists of sales of vaccines for diseases such as Japanese encephalitis, tick-borne encephalitis, and tuberculosis (TB). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Travel Vaccines Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on travel vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for travel vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The travel vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Disease: Hepatitis A; Diphtheria, Pertussis, And Tetanus (DPT); Yellow Fever; Typhoid; Hepatitis B; Measles And Mumps; Rabies; Meningococcal; Other Diseases;
• 2) By Composition: Mono Vaccines; Combination Vaccines
• 3) By Booking Channel: Online Booking; In-Person Booking
• 4) By Application: Domestic Travel; Outbound Travel
• Companies Mentioned: Pfizer Inc.; Johnson and Johnson; Merck & Co. Inc.; Novartis AG; Sanofi SA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Travel Vaccines Market Characteristics

3. Travel Vaccines Market Trends And Strategies

4. Travel Vaccines Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Travel Vaccines Market Size and Growth

• 5.1. Global Travel Vaccines Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Travel Vaccines Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Travel Vaccines Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Travel Vaccines Market Segmentation

• 6.1. Global Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hepatitis A
• Diphtheria, Pertussis, And Tetanus (DPT)
• Yellow Fever
• Typhoid
• Hepatitis B
• Measles And Mumps
• Rabies
• Meningococcal
• Other Diseases
• 6.2. Global Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Mono Vaccines
• Combination Vaccines
• 6.3. Global Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Online Booking
• In Person Booking
• 6.4. Global Travel Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Domestic Travel
• Outbound Travel

7. Travel Vaccines Market Regional And Country Analysis

• 7.1. Global Travel Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Travel Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Travel Vaccines Market

• 8.1. Asia-Pacific Travel Vaccines Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Travel Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Travel Vaccines Market

• 9.1. China Travel Vaccines Market Overview
• 9.2. China Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Travel Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Travel Vaccines Market

• 10.1. India Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Travel Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Travel Vaccines Market

• 11.1. Japan Travel Vaccines Market Overview
• 11.2. Japan Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Travel Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Travel Vaccines Market

• 12.1. Australia Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Travel Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Travel Vaccines Market

• 13.1. Indonesia Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Travel Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Travel Vaccines Market

• 14.1. South Korea Travel Vaccines Market Overview
• 14.2. South Korea Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Travel Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Travel Vaccines Market

• 15.1. Western Europe Travel Vaccines Market Overview
• 15.2. Western Europe Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Travel Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Travel Vaccines Market

• 16.1. UK Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Travel Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Travel Vaccines Market

• 17.1. Germany Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Travel Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Travel Vaccines Market

• 18.1. France Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Travel Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Travel Vaccines Market

• 19.1. Italy Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Travel Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Travel Vaccines Market

• 20.1. Spain Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Travel Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Travel Vaccines Market

• 21.1. Eastern Europe Travel Vaccines Market Overview
• 21.2. Eastern Europe Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Travel Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Travel Vaccines Market

• 22.1. Russia Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Travel Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Travel Vaccines Market

• 23.1. North America Travel Vaccines Market Overview
• 23.2. North America Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Travel Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Travel Vaccines Market

• 24.1. USA Travel Vaccines Market Overview
• 24.2. USA Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Travel Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Travel Vaccines Market

• 25.1. Canada Travel Vaccines Market Overview
• 25.2. Canada Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Travel Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Travel Vaccines Market

• 26.1. South America Travel Vaccines Market Overview
• 26.2. South America Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Travel Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Travel Vaccines Market

• 27.1. Brazil Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Travel Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Travel Vaccines Market

• 28.1. Middle East Travel Vaccines Market Overview
• 28.2. Middle East Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Travel Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Travel Vaccines Market

• 29.1. Africa Travel Vaccines Market Overview
• 29.2. Africa Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Travel Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Travel Vaccines Market Competitive Landscape And Company Profiles

• 30.1. Travel Vaccines Market Competitive Landscape
• 30.2. Travel Vaccines Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Johnson and Johnson
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Merck & Co. Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Novartis AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Sanofi SA
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Travel Vaccines Market Other Major And Innovative Companies

• 31.1. AstraZeneca PLC.
• 31.2. GlaxoSmithKline plc
• 31.3. Moderna Inc.
• 31.4. BioNTech Europe GmbH
• 31.5. Biological E. Limited
• 31.6. Bausch Health Companies Inc.
• 31.7. Takeda Pharmaceutical Company Limited
• 31.8. Novavax Inc.
• 31.9. Emergent BioSolutions UK
• 31.10. Serum Institute of India Pvt. Ltd.
• 31.11. Dynavax Technologies
• 31.12. Bavarian Nordic A/S
• 31.13. Valneva SE
• 31.14. Panacea Biotec
• 31.15. Vabiotech

32. Global Travel Vaccines Market Competitive Benchmarking

33. Global Travel Vaccines Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Travel Vaccines Market

35. Travel Vaccines Market Future Outlook and Potential Analysis

• 35.1 Travel Vaccines Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Travel Vaccines Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Travel Vaccines Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer